Marco Davilla

Dr. Davilla is a Senior Member at the Moffitt Cancer Center where he serves as a physician-scientist that treats cancer patients using cell therapies and chemotherapies. Dr. Davilla is dedicated to the development of T cell therapies for cancer. He has been involved with and/or led multiple clinical trials on cellular therapies.

His research is focused on the development of novel animal mouse models for use in evaluating CAR cellular therapies, the development of new CARs (i.e. not CD19) targeting a variety of hematologic and solid tumor malignancies, and the refining and optimization of the production of therapeutic tumor-infiltrating lymphocytes (TILs) for treatment of solid tumors.